Journal of Oncology / 2011 / Article / Fig 2

Research Article

Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator System

Figure 2

Ciglitazone decreases chemotaxis in MCF-10A (a) and MCF-10CA1 cells (b). Chemotaxis to either BSA (1 mg/mL fatty-acid free BSA) or to EGF (5 ng/mL EGF in 1 mg/mL fatty acid free BSA) was performed as detailed under Section 2. Each condition was done in triplicate. Values represent total number of cells per well + SD .

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.